Cargando…
Cell-based Hyper-interleukin 6 or Hyper-interleukin 11 secreting vaccines combined with low dose cyclophosphamide in an orthotopic murine prostate cancer model
BACKGROUND: Cell based vaccines encoding Hyper-IL-6 (H6) and Hyper-IL-11 (H11) present high activity in murine melanoma and renal cancer model. We evaluated the efficacy of cellular vaccines modified with H6 or H11 combined with cyclophosphamide in orthotopic murine prostate cancer model. MATERIAL A...
Autores principales: | Mackiewicz, Jacek, Kotlarski, Marek, Dondajewska, Ewelina, Nowicka-Kotlarska, Anita, Krokowicz, Łukasz, Kazimierczak, Urszula |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Termedia Publishing House
2015
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4631279/ https://www.ncbi.nlm.nih.gov/pubmed/26557758 http://dx.doi.org/10.5114/wo.2015.52711 |
Ejemplares similares
-
Designer Cytokine Hyper Interleukin 11 (H11) is a Megakaryopoietic Factor
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2013) -
Effects of Designer Hyper-Interleukin 11 (H11) on Hematopoiesis in Myelosuppressed Mice
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2016) -
A designer hyper interleukin 11 (H11) is a biologically active cytokine
por: Dams-Kozlowska, Hanna, et al.
Publicado: (2012) -
The role of interleukin-13 in the removal of hyper-radiosensitivity by priming irradiation
por: Edin, Nina F. Jeppesen
Publicado: (2014) -
Interleukin 1 blockade withcanakinumab for Hyper IGD syndrome (HIDS)
por: Brunnner, J, et al.
Publicado: (2015)